Advanced technology and exceptional integrative solutions
1) Scientific reports, 2024
2) Test report, StandardBank, 2023
AI Cervical Cancer Screening System
Limitation of current screening
The traditional methods such as Cytology, HPV, and VIA tests have limitations in both screening and triage. Pap smear and HPV tests, despite its popularity, have shown drawbacks in reliability and accuracy. VIA test is highly dependent on skill and experience of the test provider.
Infrastructure
Need a diagnostic laboratory and infrastructure
Low sensitivity
Pap smear and HPV test are not sufficient
It takes time
Up to 7days to get a result it leads to miss follow-up
Screening for early detection is the solution,
CerviCARE AI brings the solution!!
CerviCARE® Al provides an effective measure to screen cervical cancer. The Integrated deep learning artificial intelligence predicts findings from cervix just like how experienced gynecologic oncologists would determine.
Work-flow
1.Capture_Image Quality Guide
- Apply 5% acetic acid
- Direct to the cervix, outside the body
- Follow the guide, capture pictures
2. Documentation
- Input patient information
- Integrate the patient’s medical history to improve the precision of AI-driven analysis
3. AI report
- AI result classification
- AI report for patient consultation
4. Tele-health system
- Request for expert consultation
- Detailed result with morphological findings
“Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia”
Scientific Reports (2024)14:1957
“CerviCARE® AI achieved a remarkable sensitivity of 98% for high-risk groups (P2, P3, HSIL or higher, CIN2 or higher) and a specificity of 95.5%.”
Table 4.
The diagnostic performance for detecting high-risk groups (P2 or P3). *95% Wald confidence interval.
Table 5.
The diagnostic accuracy for all lesions. *95% Wald confidence interval. † Positive predictive value. ‡ Negative predictive value.
Ongoing Global Research
“Digital cervicography: Analysis of non-inferiority to conventional colposcopy”
Federal University Hospital of Sao Paulo, Brazil
“Application of Deep Learning Machine Assisted ‘CerviCARE® AI’ for Pre-cancerous Lesion of Cervix”
Thammasat University, Thailand
“Evaluation of Cervical Cancer Screening Results Using an Artificial Intelligence-Assisted Device at the National Hospital of Obstetrics and Gynecoligy in Vietnam”
National Hospital of Obstetrics and Gynecoligy, Vietnam
“Validation of Artificial Intelligence-based Analysis Software for Cervical Screening in Mongolia: Preliminary Results”
National Center for maternal and Child Health, Mongolia
Testimonials
“I found the CerviCARE® AI is accurate and cost-effective… if we use VIA test, this matter is objective. If we use CerviCARE® AI, it is subjective and it is great”
Vietnam Dr.
“I support CerviCARE® AI as a cervical cancer screening method. Based on AI results, physicians or even healthcare professionals can make immediate screening, triage, diagnosis, and treatment decisions for cervical cancer.”
Thailand Dr.
“CerviCARE® AI has been implemented in various hospitals across Mongolia over the past year….Important research conducted in collaboration with the National Center for Maternal and Child Health of Mongolia.”
Mongolia Dr.
Platform
No Limitation
Based on AI Algorithm
CI Supporting Program
Point-of-Care Test
Simple Procedure
No Consumable
